New asthma drug candidate tested in healthy volunteers for first time
NCT ID NCT05790694
First seen May 04, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This early-stage study tested a single injection of an experimental drug called HBM9378 in 50 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat asthma but to gather important safety and drug-level information for future studies. Participants were healthy volunteers, not asthma patients, and the study is already complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Fifth People's Hospital of Chengdu
Sichuan, Chengdu, China
Conditions
Explore the condition pages connected to this study.